British Pharmacopoeia 2025
Helping you to access quality and compliance, quickly, easily and with confidence.
New, legally enforced standards, available from 1 August 2024. All European Pharmacopoeia texts included.
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.
It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
New for the BP 2025
The BP 2025 supersedes the BP 2024 and becomes legally effective on 1 January 2025. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.
British Pharmacopoeia 2025
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
Available formats:
Single-user licences and packages
Visit the BP website to purchase and view single-user licence package options.
*Single-user licences are granted solely to one designated holder.
Multi-user licences
If online access for more than one online user is required, organisations can enjoy cost-effective simultaneous access to the full text of the BP 2024 edition, on workstations, laptops and other portable devices.
-
For multi-user licences, call or email our dedicated team:
- +44(0) 1603 985982
- pharmahealth@tso.co.uk
Online customers can select from additional add-on options such as:
- BP Archive - to get access to all BP editions from 2014 to date
- British Approved Names (BAN) 2023 - giving access to this reference source of medicinal substance names
British Approved Names (BAN) 2022: Supplement No.2
The British Approved Names (BAN) 2022: Supplement No.2, includes details of names that have been issued since the publication of BAN 2022.
Available formats:
British Approved Names (BAN) 2022: Supplement No.1
The British Approved Names (BAN) 2022: Supplement No.1 is a British Pharmacopoeia publication.
Available formats:
British Approved Names (BAN) 2022: Main Edition
The British Approved Names 2022: Main Edition, consolidates the drug names published in the British Approved Names (BAN) 2017 and the International Nonproprietary Names (rINNs).